Stability is the Key - - BioPharm International

ADVERTISEMENT

Stability is the Key


BioPharm International


The criteria for dried-protein stability include minimum lyophilization-induced unfolding, with proteins native in the dried solid; a powder with Tg higher than the desired storage temperature; low residual moisture (<1%) in the cake; and formulation conditions (such as pH) that inhibit chemical degradation reactions unaffected by glass transition (such as oxidation). The goal is to design the fastest and most robust (acceptable quality even with variations in operating parameters) processing cycle: one that consumes the least amount of energy, does not compromise product quality, and produces a mechanically strong, rapidly dissoluble cake. The cycle must be controlled for reproducibility and rapid correction of any problems that develop.


Workers load a large-scale lyophilizer.
The challenges. Early lyophilized products were found to be inactive after rehydration, but no one knew where the damage had occurred. Infrared spectroscopy showed that proteins were unfolded in the dried solids. Stabilizers were added to prevent unfolding. Proteins need protection to maintain native structure during lyophilization. Sucrose can protect them during both freezing and drying. Until recently, assessing the necessary additives was impossible until after rehydration. However, Fourier-transform infrared (FTIR) spectroscopy allows the study of protein structures in any state, enabling scientists to discover that all unprotected proteins, except granulocyte colony-stimulating factor, unfold during lyophilization. They either regain their native conformation during rehydration (reversible unfolding) or they aggregate. To prevent aggregation, scientists prevent unfolding by using a stabilizer to retain the native structure in the dried product. Proteins that do refold are also protected by stabilizers from unfolding, which is a critical parameter for successful lyophilization.


A New Stability Method for Vaccines
John Carpenter of the University of Colorado is a recognized expert in protein lyophilization. In their chapter in Biotechnology and BioPharmaceutical Manufacturing, Processing, and Preservation, Carpenter and Byeong Chang, founder of Integrity Biosolution, noted that formulators should watch for contaminants in their excipients. For example, mannitol may crystallize during short-term transient heating. "Think about the temperature of warehouses in tropical countries," they cautioned. "Amorphous mannitol can crystallize on exposure to >45C."


blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

FDA Approves Pfizer's Trumenba for the Prevention of Meningitis B
October 30, 2014
EMA: Extrapolation Across Indications for Biosimilars a Possibility
October 30, 2014
Bristol-Myers Squibb Announces Agreement to Acquire HER2-Targeted Cancer Treatment
October 29, 2014
Contract Research and Manufacturing Organization Paragon Bioservices Raises $13 Million
October 28, 2014
Yale and Gilead Extend Sequencing Initiative
October 28, 2014
Author Guidelines
Source: BioPharm International,
Click here